Alector, Inc. (ALEC) vs Nkarta, Inc. (NKTX)

Alector, Inc. and Nkarta, Inc. are both Biotechnology companies. Alector, Inc. and Nkarta, Inc. are of similar size ($214.4M and $204.1M). Nkarta, Inc. has the higher net margin (0.00% vs −850.1%) and the lower return on invested capital (−127.2% vs 0.00%). Across the 13 metrics below, Nkarta, Inc. leads on 8 and Alector, Inc. on 5.

Valuation

Metric ALEC NKTX Biotechnology median
P/E n/m n/m 7.88
P/S 15.65 n/m 11.47
P/B n/m 0.83 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.49 n/m 10.73
Earnings yield (56.41%) (57.09%) (28.84%)
Free cash flow yield (73.03%) (45.84%) (23.03%)

Profitability

Metric ALEC NKTX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (38.76%) (57.72%)
Return on assets (42.15%) (29.86%) (49.22%)
Return on invested capital 0.00% (127.22%) 0.00%

Growth

Metric ALEC NKTX Biotechnology median
Revenue growth (TTM) (82.91%) — 5.64%
EPS growth (last fiscal year) (13.01%) 11.88% —
Revenue growth, 5-year CAGR (0.05%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC NKTX Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 7.98 4.73
Net debt to EBITDA 1.61 2.35 0.96

Dividend

Metric ALEC NKTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALEC NKTX Biotechnology median
Market cap 214.38m 204.13m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack